Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer

  • End date
    Jan 7, 2022
  • participants needed
  • sponsor
    University Hospital, Grenoble
Updated on 7 March 2021


The objective of this study is to evaluate a new medical device in the management of pain. The principle of this new treatment is based on the emission of electromagnetic radiation in millimeter band. This new modality of pain management is evaluated in a perioperative management in patients undergoing surgery for aortic valve replacement.

The hypothesis is that the use of this medical device in perioperative would reduce the consumption of postoperative morphine with an identical quality of analgesia. The decline in morphine consumption would allow a decrease in opioid adverse effects.

Condition Aortic Valve Replacement
Treatment Medical device - electronic-pain killer
Clinical Study IdentifierNCT03889288
SponsorUniversity Hospital, Grenoble
Last Modified on7 March 2021


Yes No Not Sure

Inclusion Criteria

candidate for an aortic valve replacement with extra-corporal flow
wrist size between 14.5 and 18.5 centimeters (for the experimental group)
patient affiliated to social security
signature of the informed consent (for the experimental group)

Exclusion Criteria

patient with diabetes
patient with an evolutive cancer
patient with cardiac assistance
patient under the influence of opioid in the 48 hours before the surgery
patient deprived of liberty by judicial or administrative decision
patient subject to legal protection or unable to express his consent (guardianship or curators)
Exclusion Criteria for the experimental group
patient with diabetes
patient with an evolutive cancer
patient with surgery planning within 48 hours
patient with cardiac assistance
patient under the influence of opioid in the 48 hours before the surgery
patient suffering from a dermatological disease such as oozing dermatitis, hyper sweating, or an unhealed lesion in the wrists
patient who has a piercing in the wrist or another metal material
patient known for having a multi-resistant bacterial strain
protected person referred to in Articles L1121-5 to L1121-8 of the Code of Public Health
exclusion period of another interventional study
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note